Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: breakthrough therapy designation
FDA Approves First Treatment for Eosinophilic Esophagitis (EoE), a Chronic Immune...
News Wire ~ 3rd Party Press Release
-
2022/05/23
EoE is a chronic inflammatory disorder in which eosinophils, a type of white blood cell, are found in the tissue of the esophagus.
Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple...
News Wire ~ 3rd Party Press Release
-
2019/08/01
NIH and partners to assess whether Omalizumab can reduce allergic reactions.
FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies
News Wire ~ 3rd Party Press Release
-
2018/08/13
Breakthrough Therapy Designation was granted on the basis of data from seven clinical studies assessing the efficacy and safety of Xolair against a range of food allergens including peanut, milk, egg and others.
Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut...
Dave Bloom
-
2017/05/17
First of 440 patients enrolled in study of AR101.
Breakthrough Food Allergy Therapies and the Big Business Behind Them
Dave Bloom
-
2015/10/28
What it means to be a breakthrough therapy, who is developing them, how they work, and the (big) business drivers behind them.